GlassScriptPhysician profile
Janet F Lin
NPI 1679536130
$271.47
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $217 · 2020: $54.56.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $46.46 | 2019-2020 | |
| Medtronic USA, INC. | $43.56 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $39.48 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $30.41 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $29.40 | 2019 | |
| Emd Serono, INC. | $19.93 | 2019 | |
| Biogen, INC. | $18.86 | 2019 | |
| Lilly USA, LLC | $16.91 | 2019 | |
| Vertical Pharmaceuticals, LLC | $15.48 | 2019 | |
| Pfizer INC. | $10.98 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janet Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.